substance p has been researched along with Spinal Cord Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, SZ; Guo, CQ; Hu, B; Li, XH; Liu, L; Liu, NG; Lu, J; Ma, HF; Sun, HM | 1 |
| Björkman, R; Hallman, KM; Hedner, J; Hedner, T; Henning, M | 1 |
| Hashimoto, S; Imasato, H; Inoue, A; Komori, H; Nagata, K | 1 |
| Nielsen, JB; Petersen, T; Schrøder, HD | 1 |
| Brodin, E; Foster, GA; Gage, FH; Maxwell, DJ; Roberts, MH; Sharp, T | 1 |
| Paulsson, I; Post, C | 1 |
| Freedman, J; Hökfelt, T; Jonsson, G; Post, C | 1 |
| Cramer, H; Gagnieu, MC; Renaud, B; Rissler, K; Rösler, N | 1 |
| Kawamura, M; Kuraishi, Y; Masu, Y; Minami, M; Nakanishi, S; Satoh, M; Yamaguchi, T | 1 |
2 trial(s) available for substance p and Spinal Cord Diseases
| Article | Year |
|---|---|
Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid.
Topics: Activities of Daily Living; beta-Endorphin; Humans; Low Back Pain; Neuropeptides; Pain; Pain Measurement; Radioimmunoassay; Spinal Cord Diseases; Substance P | 1997 |
Intravesical capsaicin in patients with detrusor hyper-reflexia--a placebo-controlled cross-over study.
Topics: Administration, Intravesical; Anesthetics, Local; Capsaicin; Cross-Over Studies; Female; Humans; Lidocaine; Male; Middle Aged; Premedication; Reflex, Abnormal; Spinal Cord Diseases; Substance P; Time Factors; Urinary Bladder; Urinary Bladder, Neurogenic; Urodynamics | 1999 |
7 other study(ies) available for substance p and Spinal Cord Diseases
| Article | Year |
|---|---|
[Effect of acupotomy lysis on SP and CCK-8 contents in hypothalamus and spinal cord in rats with transverse process syndrome of the third lumbar vertebra].
Topics: Acupuncture; Animals; Electroacupuncture; Hypothalamus; Lumbar Vertebrae; Male; Random Allocation; Rats; Sincalide; Spinal Cord; Spinal Cord Diseases; Substance P | 2008 |
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P.
Topics: Acetaminophen; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; N-Methylaspartate; Nociceptors; Rats; Rats, Sprague-Dawley; Spinal Cord Diseases; Substance P | 1994 |
Restoration of function to the denervated spinal cord after implantation of embryonic 5HT- and substance P-containing raphe neurones.
Topics: Animals; Brain Tissue Transplantation; Denervation; Female; Fetal Tissue Transplantation; Neurons; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord Diseases; Substance P; Transplantation, Heterotopic | 1990 |
Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.
Topics: Analgesics; Animals; Injections, Spinal; Male; Pain; Rats; Rats, Inbred Strains; Spinal Cord; Spinal Cord Diseases; Substance P | 1985 |
Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.
Topics: Animals; Injections, Spinal; Male; Necrosis; Rats; Rats, Inbred Strains; Spinal Cord; Spinal Cord Diseases; Substance P; Thyrotropin-Releasing Hormone | 1986 |
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
Topics: Adult; Cerebrospinal Fluid Proteins; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Immunoglobulin G; Male; Middle Aged; Peripheral Nervous System Diseases; Reference Values; Somatostatin; Spinal Cord Diseases; Substance P | 1988 |
Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception.
Topics: Animals; Gene Expression Regulation; Inflammation; Male; Pain; Protein Precursors; Rats; Rats, Inbred Strains; RNA, Messenger; Sensory Thresholds; Spinal Cord Diseases; Substance P; Tachykinins; Time Factors | 1989 |